Literature DB >> 15864353

Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.

Yoshihisa Yamano1, Norihiro Takenouchi, Hong-Chuan Li, Utano Tomaru, Karen Yao, Christian W Grant, Dragan A Maric, Steven Jacobson.   

Abstract

CD4(+)CD25(+) Tregs are important in the maintenance of immunological self tolerance and in the prevention of autoimmune diseases. As the CD4(+)CD25(+) T cell population in patients with human T cell lymphotropic virus type I-associated (HTLV-I-associated) myelopathy/tropical spastic paraparesis (HAM/TSP) has been shown to be a major reservoir for this virus, it was of interest to determine whether the frequency and function of CD4(+)CD25(+) Tregs in HAM/TSP patients might be affected. In these cells, both mRNA and protein expression of the forkhead transcription factor Foxp3, a specific marker of Tregs, were lower than those in CD4(+)CD25(+) T cells from healthy individuals. The virus-encoded transactivating HTLV-I tax gene was demonstrated to have a direct inhibitory effect on Foxp3 expression and function of CD4(+)CD25(+) T cells. This is the first report to our knowledge demonstrating the role of a specific viral gene product (HTLV-I Tax) on the expression of genes associated with Tregs (in particular, foxp3) resulting in inhibition of Treg function. These results suggest that direct human retroviral infection of CD4(+)CD25(+) T cells may be associated with the pathogenesis of HTLV-I-associated neurologic disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864353      PMCID: PMC1087174          DOI: 10.1172/JCI23913

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

2.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

3.  Inhibition of human CD4(+)CD25(+high) regulatory T cell function.

Authors:  Clare Baecher-Allan; Vissia Viglietta; David A Hafler
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

Review 4.  Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).

Authors:  Mitsuhiro Osame
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

Review 5.  Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.

Authors:  Steven Jacobson
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Authors:  Roli Khattri; Tom Cox; Sue-Ann Yasayko; Fred Ramsdell
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

8.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 9.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

10.  Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

Authors:  T Takahashi; T Tagami; S Yamazaki; T Uede; J Shimizu; N Sakaguchi; T W Mak; S Sakaguchi
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  65 in total

1.  A tax on luxury: HTLV-I infection of CD4+CD25+ Tregs.

Authors:  Robert S Fujinami
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 2.  Natural regulatory T cells and persistent viral infection.

Authors:  Shuo Li; Eric J Gowans; Claire Chougnet; Magdalena Plebanski; Ulf Dittmer
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 3.  Role of Exosomes in Human Retroviral Mediated Disorders.

Authors:  Monique Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-14       Impact factor: 4.147

4.  Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.

Authors:  T Luna; S B Santos; M Nascimento; M A F Porto; A L Muniz; E M Carvalho; A R Jesus
Journal:  Braz J Med Biol Res       Date:  2011-10-22       Impact factor: 2.590

5.  Tax posttranslational modifications and interaction with calreticulin in MT-2 cells and human peripheral blood mononuclear cells of human T cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.

Authors:  Fernando Medina; Sebastian Quintremil; Carolina Alberti; Andres Barriga; Luis Cartier; Javier Puente; Eugenio Ramírez; Arturo Ferreira; Yuetsu Tanaka; Maria Antonieta Valenzuela
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01-24       Impact factor: 2.205

Review 6.  Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.

Authors:  Yorifumi Satou; Masao Matsuoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

7.  Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

Authors:  Mineki Saito
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-10

8.  HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.

Authors:  Natsumi Araya; Tomoo Sato; Hitoshi Ando; Utano Tomaru; Mari Yoshida; Ariella Coler-Reilly; Naoko Yagishita; Junji Yamauchi; Atsuhiko Hasegawa; Mari Kannagi; Yasuhiro Hasegawa; Katsunori Takahashi; Yasuo Kunitomo; Yuetsu Tanaka; Toshihiro Nakajima; Kusuki Nishioka; Atae Utsunomiya; Steven Jacobson; Yoshihisa Yamano
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

Review 9.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

10.  Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.

Authors:  Yoshihisa Yamano; Natsumi Araya; Tomoo Sato; Atae Utsunomiya; Kazuko Azakami; Daisuke Hasegawa; Toshihiko Izumi; Hidetoshi Fujita; Satoko Aratani; Naoko Yagishita; Ryoji Fujii; Kusuki Nishioka; Steven Jacobson; Toshihiro Nakajima
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.